Oligonucleotide CDMO

Oligonucleotide CDMO
Product Description

ST Pharm offers top-tier customized oligonucleotide CDMO services under stringent cGMP conditions. We enhance raw material supply chain resilience by leveraging in-house manufacturing capabilities of nucleosides/phosphormaidites. Our two state-of-the-art facilities, expected to reach a 7.0 mol capacity by 2025 with the expansion of second oligo plant, are fully equipped to meet your oligo API needs. Our comprehensive oligonucleotide production fulfills demands from preclinical to commercial supply. Oligonucleotide theraperutics coverage : - Antisense Oligonucleotide (ASO) - Small interfering RNA (siRNA) - Single guide RNA (sgRNA) - GalNAc congugate - PN chemistry with newly developed Liquid Phase Oligonucleotide Synthesis (LPOS)

ST Pharm Co. Ltd

  • KR
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Intermediates Manufacturer
Specifications
  • Supplied from
    Korea, Republic Of

ST Pharm Co. Ltd

  • KR
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Intermediates Manufacturer

More Products from ST Pharm Co. Ltd (99)

ST Pharm Co. Ltd resources (2)